IMMUNITYBIO, INC. Deferred Income Tax Expense (Benefit)
IMMUNITYBIO, INC. (IBRX) reported Deferred Income Tax Expense (Benefit) of -$139.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-23
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was -$8.00K.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for the quarter ending 2021-09-30 was $0.00.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for the quarter ending 2021-03-31 was $0.00.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for fiscal 2025 was -$139.00K.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for fiscal 2023 was -$14.00K.
- IMMUNITYBIO, INC. deferred income tax expense (benefit) for fiscal 2022 was -$4.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$139.00K 10-K · filed 2026-02-23 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-23 | ||||
| 2023-12-31 | -$14.00K 10-K · filed 2026-02-23 | ||||
| 2022-12-31 | -$4.00K 10-K · filed 2023-03-01 | ||||
| 2021-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$8.00K derived: sum of 2 quarters · filed 2023-03-01 | -$8.00K derived: sum of 3 quarters · filed 2023-03-01 | -$8.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | -$207.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | -$207.00K derived: sum of 3 quarters · filed 2023-03-01 | -$1.91M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 | -$207.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.91M derived: sum of 3 quarters · filed 2023-03-01 | -$1.87M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.91M derived: sum of 2 quarters · filed 2023-03-01 | -$1.87M derived: sum of 3 quarters · filed 2023-03-01 | -$2.94M 10-K · filed 2023-03-01 | $0.00 10-K · filed 2021-03-04 |
| 2020-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.66M derived: sum of 2 quarters · filed 2021-11-12 | -$2.73M 10-Q · filed 2021-11-12 | -$2.74M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.03M 10-Q · filed 2021-08-12 | -$1.04M derived: sum of 3 quarters · filed 2022-03-01 | -$1.04M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$1.07M 10-Q · filed 2021-05-14 | -$1.07M derived: sum of 2 quarters · filed 2022-03-01 | -$1.07M derived: sum of 3 quarters · filed 2022-03-01 | -$1.07M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$8.00K derived: sum of 2 quarters · filed 2022-03-01 | -$8.00K derived: sum of 3 quarters · filed 2022-03-01 | -$8.00K 10-K · filed 2022-03-01 | $0.00 10-K · filed 2020-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | -$122.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | -$122.00K derived: sum of 3 quarters · filed 2021-03-04 | -$250.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$122.00K derived: sum of 2 quarters · filed 2021-03-04 | -$250.00K derived: sum of 3 quarters · filed 2021-03-04 | -$374.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | -$122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$250.00K derived: sum of 2 quarters · filed 2021-03-04 | -$374.00K derived: sum of 3 quarters · filed 2021-03-04 | -$498.00K 10-K · filed 2021-03-04 | |
| 2018-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$252.00K derived: sum of 2 quarters · filed 2019-11-05 | -$376.00K 10-Q · filed 2019-11-05 | -$558.00K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2018-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$248.00K 10-Q · filed 2019-08-06 | -$430.00K derived: sum of 3 quarters · filed 2020-03-25 | -$528.00K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2018-03-31 | -$124.00K 10-Q · filed 2019-05-08 | -$306.00K derived: sum of 2 quarters · filed 2020-03-25 | -$404.00K derived: sum of 3 quarters · filed 2020-03-25 | -$528.00K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2017-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$280.00K derived: sum of 2 quarters · filed 2020-03-25 | -$404.00K derived: sum of 3 quarters · filed 2020-03-25 | -$497.00K 10-K · filed 2020-03-25 | |
| 2017-09-30 | -$98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$222.00K derived: sum of 2 quarters · filed 2018-11-07 | -$315.00K 10-Q · filed 2018-11-07 | -$467.00K derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$217.00K 10-Q · filed 2018-08-06 | -$369.00K derived: sum of 3 quarters · filed 2019-03-13 | -$419.00K derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-03-31 | -$93.00K 10-Q · filed 2018-05-07 | -$245.00K derived: sum of 2 quarters · filed 2019-03-13 | -$295.00K derived: sum of 3 quarters · filed 2019-03-13 | -$523.00K derived: sum of 4 quarters · filed 2019-03-13 | |
| 2016-12-31 | -$152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$202.00K derived: sum of 2 quarters · filed 2019-03-13 | -$430.00K derived: sum of 3 quarters · filed 2019-03-13 | -$575.00K 10-K · filed 2019-03-13 | |
| 2016-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$278.00K derived: sum of 2 quarters · filed 2017-11-07 | -$423.00K 10-Q · filed 2017-11-07 | -$725.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | -$228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$373.00K 10-Q · filed 2017-08-07 | -$675.00K derived: sum of 3 quarters · filed 2018-03-12 | ||
| 2016-03-31 | -$145.00K 10-Q · filed 2017-05-08 | -$447.00K derived: sum of 2 quarters · filed 2018-03-12 | |||
| 2015-12-31 | -$302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$302.00K 10-K · filed 2018-03-12 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |